Paul Manning
Patrimonio netto: 564 M $ in data 31/05/2026
Patrimonio netto: 564 M $ in data 31/05/2026
Paul B. Manning was the founder of PBM Products LLC, founded in 1997, where the title held was President & Chief Executive Officer.
Mr. Manning is the founder of PBM Capital Group LLC, founded in 2010, holding the titles of Chairman and CEO.
Mr. Manning is also the founder of Able Laboratories, Inc...
Mr. Manning is President & Chief Executive Officer at PBM Capital Investments LLC.
Mr. Manning is Chairman at Candel Therapeutics, Inc. since 2021.
Mr. Manning is Chairman at Xalud Therapeutics, Inc. Mr. Manning is Chairman at Verrica Pharmaceuticals, Inc. since 2017.
Mr. Manning is Director at PatientsLikeMe LLC since 2022.
Mr. Manning is Director at The Foundation Fighting Blindness, Inc. Mr. Manning is Director at Foundation Fighting Blindness Clinical Research Institute.
Mr. Manning is Director at PBM Pharmaceuticals, Inc. Mr. Manning is Independent Director at ArcherDX LLC since 2015.
Mr. Manning is Director at Tolerion, Inc. Mr. Manning is Director at UVA Health Foundation.
Mr. Manning is Independent Director at Liquidia Corp.
since 2020.
Mr. Manning was Chairman at Dova Pharmaceuticals, Inc. from 2017 to 2019.
Mr. Manning was Director at QIAGEN Beverly LLC.
Mr. Manning was Director at Gen9, Inc. Mr. Manning was Director at Advanz Pharma Corp.
Ltd. from 2014 to 2015.
Mr. Manning was Independent Director at Novartis Gene Therapies, Inc. from 2014 to 2018.
Mr. Manning was Independent Director at Taysha Gene Therapies, Inc. from 2020 to 2023.
Mr. Manning was Director at Liquidia PAH LLC from 2018 to 2020.
Mr. Manning was Executive Vice President & General Manager at Perrigo Co. from 2010 to 2014.
Mr. Manning was Principal at Beta-Pro LLC.
Mr. Manning completed undergraduate education at the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIQUIDIA CORPORATION 6,47% | 16/06/2026 | 5.755.992 ( 6,47% ) | 356 M $ | 31/05/2026 |
| 31/03/2026 | 22.737.407 ( 8,33% ) | 133 M $ | 31/05/2026 | |
| 30/06/2026 | 5.748.279 ( 7,85% ) | 48 M $ | 31/05/2026 | |
| 25/11/2025 | 4.558.183 ( 26,53% ) | 26 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Presidente | 01/12/2017 |
| LIQUIDIA CORPORATION | Direttore/Membro del Consiglio | 18/11/2020 |
| CANDEL THERAPEUTICS, INC. | Presidente | 15/07/2021 |
PatientsLikeMe LLC
PatientsLikeMe LLC Packaged SoftwareTechnology Services Operates online health communities for patients | Direttore/Membro del Consiglio | 19/01/2022 |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Presidente | - |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Direttore/Membro del Consiglio | - |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Direttore/Membro del Consiglio | 01/01/2015 |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Direttore/Membro del Consiglio | - |
| ░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 25 |
|---|---|
Able Laboratories, Inc.
Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Perrigo Co.
Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets pharmaceutical and nutritional products | Health Technology |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Health Technology |
PatientsLikeMe LLC
PatientsLikeMe LLC Packaged SoftwareTechnology Services Operates online health communities for patients | Technology Services |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PBM Products LLC
PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables Markets and distributes nutritional and pharmaceutical products | Consumer Non-Durables |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Finance |
Beta-Pro LLC | |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Finance |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
Advanz Pharma Corp. Ltd.
Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Health Technology |
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pbm Capital Investments LLC | |
UVA Health Foundation
UVA Health Foundation Internet Software/ServicesTechnology Services Operates a healthcare platform | Technology Services |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale